Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Herrlinger

Showing results (91-100 of 243) with videos related to

Pageof 25
Sort By:
Journal of Cancer Research and Clinical Oncology|April 24, 2017
Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trialUlrich Herrlinger, Niklas Schäfer, Rolf Fimmers, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 23, 2021
Chasing a rarity: a retrospective single-center evaluation of prognostic factors in primary gliosarcomaCas S Dejonckheere, Alexander M C Böhner, David Koch, et al.
Experimental Hematology & Oncology|December 11, 2012
Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapySied Kebir, Klaus Kuchelmeister, Pitt Niehusmann, et al.
Molecular Imaging|August 19, 2008
Multimodal imaging of neural progenitor cell fate in rodentsYannic Waerzeggers, Markus Klein, Hrvoje Miletic, et al.
Journal of Neuro-Oncology|September 29, 2020
Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survivalMatthias Schneider, Anna-Laura Potthoff, Elisa Scharnböck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Vemurafenib for leptomeningeal melanomatosisNiklas Schäfer, Björn Scheffler, Moritz Stuplich, et al.
International Journal of Molecular Sciences|October 2, 2020
Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic SignatureTheophilos Tzaridis, Katrin S Reiners, Johannes Weller, et al.
Journal of Translational Medicine|March 22, 2019
Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumorsNiklas Schäfer, Gerrit H Gielen, Laurèl Rauschenbach, et al.
Journal of Neuro-Oncology|August 4, 2021
Red blood cell distribution width to platelet ratio substantiates preoperative survival prediction in patients with newly-diagnosed glioblastomaMatthias Schneider, Niklas Schäfer, Stefanos Apallas, et al.
Annals of Neurology|September 27, 2002
Gliomatosis cerebri: molecular pathology and clinical courseUlrich Herrlinger, Jörg Felsberg, Wilhelm Küker, et al.
Pageof 25

Showing results (91-100 of 243) with videos related to

Sort By:
Pageof 25
Journal of Cancer Research and Clinical Oncology|April 24, 2017
Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trialUlrich Herrlinger, Niklas Schäfer, Rolf Fimmers, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 23, 2021
Chasing a rarity: a retrospective single-center evaluation of prognostic factors in primary gliosarcomaCas S Dejonckheere, Alexander M C Böhner, David Koch, et al.
Experimental Hematology & Oncology|December 11, 2012
Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapySied Kebir, Klaus Kuchelmeister, Pitt Niehusmann, et al.
Molecular Imaging|August 19, 2008
Multimodal imaging of neural progenitor cell fate in rodentsYannic Waerzeggers, Markus Klein, Hrvoje Miletic, et al.
Journal of Neuro-Oncology|September 29, 2020
Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survivalMatthias Schneider, Anna-Laura Potthoff, Elisa Scharnböck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Vemurafenib for leptomeningeal melanomatosisNiklas Schäfer, Björn Scheffler, Moritz Stuplich, et al.
International Journal of Molecular Sciences|October 2, 2020
Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic SignatureTheophilos Tzaridis, Katrin S Reiners, Johannes Weller, et al.
Journal of Translational Medicine|March 22, 2019
Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumorsNiklas Schäfer, Gerrit H Gielen, Laurèl Rauschenbach, et al.
Journal of Neuro-Oncology|August 4, 2021
Red blood cell distribution width to platelet ratio substantiates preoperative survival prediction in patients with newly-diagnosed glioblastomaMatthias Schneider, Niklas Schäfer, Stefanos Apallas, et al.
Annals of Neurology|September 27, 2002
Gliomatosis cerebri: molecular pathology and clinical courseUlrich Herrlinger, Jörg Felsberg, Wilhelm Küker, et al.
Pageof 25